Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of genomic information to optimize cancer chemotherapy.

Seminars in oncology - 1 Apr 2011

Innocenti Federico, Cox Nancy J, Dolan M Eileen

Abstract excerpt

The field of pharmacogenomics is focused on the characterization of genetic factors contributing to the response of patients to pharmacological interventions. Drug response and toxicity are complex traits; therefore the effects are likely influenced by multiple genes. The investigation of the genetic basis of drug response has evolved from a focus on single genes to relevant pathways to the entire genome....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genome-Wide Association Study
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pancreatic and Hepatic Oncology Research

Share to Pharmacogenetics and Drug Metabolism

Share to Polymorphism, Single Nucleotide

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 21421109
DOI: 10.1053/j.seminoncol.2011.01.005
PMCID: PMC3076508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of genomic information to optimize cancer chemotherapy.PMID 21421109Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Pharmacogenomic Characterization of US FDA-approved Cytotoxic DrugsSemantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?Semantic proximity Read ↗

Insights into the role of heritable genetic variation in the pharmacokinetics and pharmacodynamics of anticancer drugs.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Semantic proximity Read ↗

Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.